v3.26.1
SEGMENT INFORMATION- Schedule of Disaggregation of Total Net Product Revenues by Geographic Region (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Disaggregation of Revenue [Line Items]    
Total revenues $ 766,208 $ 745,145
ALDURAZYME    
Disaggregation of Revenue [Line Items]    
Total revenues 36,742 48,977
Net product revenues    
Disaggregation of Revenue [Line Items]    
Total revenues 760,078 734,644
Marketed by Company | Products excluding ALDURAZYME    
Disaggregation of Revenue [Line Items]    
Total revenues 723,336 685,667
Marketed by Company | Products excluding ALDURAZYME | United States    
Disaggregation of Revenue [Line Items]    
Total revenues 242,944 241,694
Marketed by Company | Products excluding ALDURAZYME | Europe    
Disaggregation of Revenue [Line Items]    
Total revenues 218,836 229,578
Marketed by Company | Products excluding ALDURAZYME | Latin America    
Disaggregation of Revenue [Line Items]    
Total revenues 108,164 88,282
Marketed by Company | Products excluding ALDURAZYME | Rest of world    
Disaggregation of Revenue [Line Items]    
Total revenues 153,392 126,113
Marketed by Sanofi | ALDURAZYME    
Disaggregation of Revenue [Line Items]    
Total revenues $ 36,742 $ 48,977